Dept of Rheumatology, Sahlgrenska University Hospital
Gothenburg, 413 46, Sweden
NCT Number: NCT01470638
The study aims to correlate levels of Flt3-ligand in Cerebrospinal Fluid (CSF) and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Gothenburg, 413 46, Sweden
The study aims to correlate levels of Flt3-ligand in CSF and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: June 2009 - June 2015
Göteborg University
Other
Analyzes of Cerebrospinal Fluid in Autoimmune Systemic Diseases
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05985915
Arthritis, Arthritis, Rheumatoid
Fullerton, California, United States
View Trial DetailsNCT06741969
Arthritis, Arthritis, Rheumatoid
Chula Vista, California, United States
View Trial DetailsNCT05350072
Arthritis, Arthritis, Rheumatoid
Van Nuys, California, United States
View Trial DetailsNCT06410742
Arthritis, Arthritis, Rheumatoid
Ankara, Turkey (Türkiye)
View Trial Details